Cargando…
Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin
Monoclonal antibodies (mAbs) against not only human, mouse, and rat but also rabbit, dog, cat, bovine, pig, and horse podoplanins (PDPNs) have been established in our previous studies. PDPN is used as a lymphatic endothelial cell marker in pathological diagnoses. However, mAbs against Tasmanian devi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446048/ https://www.ncbi.nlm.nih.gov/pubmed/30984883 http://dx.doi.org/10.1016/j.bbrep.2019.100631 |
_version_ | 1783408287863013376 |
---|---|
author | Furusawa, Yoshikazu Yamada, Shinji Itai, Shunsuke Nakamura, Takuro Takei, Junko Sano, Masato Harada, Hiroyuki Fukui, Masato Kaneko, Mika K. Kato, Yukinari |
author_facet | Furusawa, Yoshikazu Yamada, Shinji Itai, Shunsuke Nakamura, Takuro Takei, Junko Sano, Masato Harada, Hiroyuki Fukui, Masato Kaneko, Mika K. Kato, Yukinari |
author_sort | Furusawa, Yoshikazu |
collection | PubMed |
description | Monoclonal antibodies (mAbs) against not only human, mouse, and rat but also rabbit, dog, cat, bovine, pig, and horse podoplanins (PDPNs) have been established in our previous studies. PDPN is used as a lymphatic endothelial cell marker in pathological diagnoses. However, mAbs against Tasmanian devil PDPN (tasPDPN), which are useful for immunohistochemical analysis, remain to be developed. Herein, mice were immunized with tasPDPN-overexpressing Chinese hamster ovary (CHO)-K1 (CHO/tasPDPN) cells, and hybridomas producing mAbs against tasPDPN were screened using flow cytometry. One of the mAbs, PMab-233 (IgG(1), kappa), specifically detected CHO/tasPDPN cells by flow cytometry and recognized tasPDPN protein by western blotting. Furthermore, PMab-233 strongly detected CHO/tasPDPN cells by immunohistochemistry. These findings suggest that PMab-233 may be useful as a lymphatic endothelial cell marker of the Tasmanian devil. |
format | Online Article Text |
id | pubmed-6446048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-64460482019-04-12 Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin Furusawa, Yoshikazu Yamada, Shinji Itai, Shunsuke Nakamura, Takuro Takei, Junko Sano, Masato Harada, Hiroyuki Fukui, Masato Kaneko, Mika K. Kato, Yukinari Biochem Biophys Rep Research Article Monoclonal antibodies (mAbs) against not only human, mouse, and rat but also rabbit, dog, cat, bovine, pig, and horse podoplanins (PDPNs) have been established in our previous studies. PDPN is used as a lymphatic endothelial cell marker in pathological diagnoses. However, mAbs against Tasmanian devil PDPN (tasPDPN), which are useful for immunohistochemical analysis, remain to be developed. Herein, mice were immunized with tasPDPN-overexpressing Chinese hamster ovary (CHO)-K1 (CHO/tasPDPN) cells, and hybridomas producing mAbs against tasPDPN were screened using flow cytometry. One of the mAbs, PMab-233 (IgG(1), kappa), specifically detected CHO/tasPDPN cells by flow cytometry and recognized tasPDPN protein by western blotting. Furthermore, PMab-233 strongly detected CHO/tasPDPN cells by immunohistochemistry. These findings suggest that PMab-233 may be useful as a lymphatic endothelial cell marker of the Tasmanian devil. Elsevier 2019-04-01 /pmc/articles/PMC6446048/ /pubmed/30984883 http://dx.doi.org/10.1016/j.bbrep.2019.100631 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Article Furusawa, Yoshikazu Yamada, Shinji Itai, Shunsuke Nakamura, Takuro Takei, Junko Sano, Masato Harada, Hiroyuki Fukui, Masato Kaneko, Mika K. Kato, Yukinari Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin |
title | Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin |
title_full | Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin |
title_fullStr | Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin |
title_full_unstemmed | Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin |
title_short | Establishment of a monoclonal antibody PMab-233 for immunohistochemical analysis against Tasmanian devil podoplanin |
title_sort | establishment of a monoclonal antibody pmab-233 for immunohistochemical analysis against tasmanian devil podoplanin |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6446048/ https://www.ncbi.nlm.nih.gov/pubmed/30984883 http://dx.doi.org/10.1016/j.bbrep.2019.100631 |
work_keys_str_mv | AT furusawayoshikazu establishmentofamonoclonalantibodypmab233forimmunohistochemicalanalysisagainsttasmaniandevilpodoplanin AT yamadashinji establishmentofamonoclonalantibodypmab233forimmunohistochemicalanalysisagainsttasmaniandevilpodoplanin AT itaishunsuke establishmentofamonoclonalantibodypmab233forimmunohistochemicalanalysisagainsttasmaniandevilpodoplanin AT nakamuratakuro establishmentofamonoclonalantibodypmab233forimmunohistochemicalanalysisagainsttasmaniandevilpodoplanin AT takeijunko establishmentofamonoclonalantibodypmab233forimmunohistochemicalanalysisagainsttasmaniandevilpodoplanin AT sanomasato establishmentofamonoclonalantibodypmab233forimmunohistochemicalanalysisagainsttasmaniandevilpodoplanin AT haradahiroyuki establishmentofamonoclonalantibodypmab233forimmunohistochemicalanalysisagainsttasmaniandevilpodoplanin AT fukuimasato establishmentofamonoclonalantibodypmab233forimmunohistochemicalanalysisagainsttasmaniandevilpodoplanin AT kanekomikak establishmentofamonoclonalantibodypmab233forimmunohistochemicalanalysisagainsttasmaniandevilpodoplanin AT katoyukinari establishmentofamonoclonalantibodypmab233forimmunohistochemicalanalysisagainsttasmaniandevilpodoplanin |